Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography.

Via LE, Schimel D, Weiner DM, Dartois V, Dayao E, Cai Y, Yoon YS, Dreher MR, Kastenmayer RJ, Laymon CM, Carny JE, Flynn JL, Herscovitch P, Barry CE 3rd.

Antimicrob Agents Chemother. 2012 Aug;56(8):4391-402. doi: 10.1128/AAC.00531-12. Epub 2012 Jun 11.

PMID:
22687508
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.

Tatsumi M, Nakamoto Y, Traughber B, Marshall LT, Geschwind JF, Wahl RL.

Cancer Res. 2003 Oct 1;63(19):6252-7.

PMID:
14559811
[PubMed - indexed for MEDLINE]
Free Article
3.

(18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response.

Martinez V, Castilla-Lievre MA, Guillet-Caruba C, Grenier G, Fior R, Desarnaud S, Doucet-Populaire F, Boué F.

Int J Tuberc Lung Dis. 2012 Sep;16(9):1180-5. doi: 10.5588/ijtld.12.0010. Epub 2012 Jul 12.

PMID:
22794271
[PubMed - indexed for MEDLINE]
4.

Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment.

Davis SL, Nuermberger EL, Um PK, Vidal C, Jedynak B, Pomper MG, Bishai WR, Jain SK.

Antimicrob Agents Chemother. 2009 Nov;53(11):4879-84. doi: 10.1128/AAC.00789-09. Epub 2009 Sep 8.

PMID:
19738022
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[Characteristics of extrapulmonary tuberculosis in (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography: experience from 39 cases].

Liu GC, Gao S, Cai L, Chen QS.

Zhonghua Jie He He Hu Xi Za Zhi. 2012 Mar;35(3):184-8. Chinese.

PMID:
22781150
[PubMed - indexed for MEDLINE]
6.

Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.

Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1432-41. Epub 2005 Aug 25.

PMID:
16125870
[PubMed - indexed for MEDLINE]
7.

Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.

Namura K, Minamimoto R, Yao M, Makiyama K, Murakami T, Sano F, Hayashi N, Tateishi U, Ishigaki H, Kishida T, Miura T, Kobayashi K, Noguchi S, Inoue T, Kubota Y, Nakaigawa N.

BMC Cancer. 2010 Dec 3;10:667. doi: 10.1186/1471-2407-10-667.

PMID:
21129184
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography.

Park IN, Ryu JS, Shim TS.

Clin Nucl Med. 2008 Jan;33(1):1-3.

PMID:
18097246
[PubMed - indexed for MEDLINE]
9.

[18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?

Halter G, Buck AK, Schirrmeister H, Wurziger I, Liewald F, Glatting G, Neumaier B, Sunder-Plassmann L, Reske SN, Hetzel M.

J Thorac Cardiovasc Surg. 2004 Apr;127(4):1093-9.

PMID:
15052207
[PubMed - indexed for MEDLINE]
10.

Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.

Kim YK, Lee KW, Cho SY, Han SS, Kim SH, Kim SK, Park SJ.

Liver Transpl. 2010 Jun;16(6):767-72. doi: 10.1002/lt.22069.

PMID:
20517911
[PubMed - indexed for MEDLINE]
Free Article
11.

Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer.

Collaud S, Lardinois D, Tischler V, Steinert HC, Stahel R, Weder W.

Eur J Cardiothorac Surg. 2012 Mar;41(3):612-6. doi: 10.1093/ejcts/ezr109. Epub 2011 Dec 14.

PMID:
22219415
[PubMed - indexed for MEDLINE]
12.

Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions.

Kjellsson MC, Via LE, Goh A, Weiner D, Low KM, Kern S, Pillai G, Barry CE 3rd, Dartois V.

Antimicrob Agents Chemother. 2012 Jan;56(1):446-57. doi: 10.1128/AAC.05208-11. Epub 2011 Oct 10.

PMID:
21986820
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.

Jadvar H, Henderson RW, Conti PS.

J Comput Assist Tomogr. 2007 Mar-Apr;31(2):223-8.

PMID:
17414758
[PubMed - indexed for MEDLINE]
14.

A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.

Smyth E, Schöder H, Strong VE, Capanu M, Kelsen DP, Coit DG, Shah MA.

Cancer. 2012 Nov 15;118(22):5481-8. doi: 10.1002/cncr.27550. Epub 2012 May 1.

PMID:
22549558
[PubMed - indexed for MEDLINE]
Free Article
15.

(18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.

Orcurto V, Denys A, Voelter V, Schalenbourg A, Schnyder P, Zografos L, Leyvraz S, Delaloye AB, Prior JO.

Melanoma Res. 2012 Feb;22(1):63-9. doi: 10.1097/CMR.0b013e32834d3dcb.

PMID:
22027909
[PubMed - indexed for MEDLINE]
16.

FDG-PET/CT in the evaluation of anal carcinoma.

Cotter SE, Grigsby PW, Siegel BA, Dehdashti F, Malyapa RS, Fleshman JW, Birnbaum EH, Wang X, Abbey E, Tan B, Kodner IJ, Hunt SR, Lowney JK, Mutch MG, Dietz DW, Myerson RJ.

Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):720-5. Epub 2006 Apr 19.

PMID:
16626889
[PubMed - indexed for MEDLINE]
17.

Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET.

Bokemeyer C, Kollmannsberger C, Oechsle K, Dohmen BM, Pfannenberg A, Claussen CD, Bares R, Kanz L.

Br J Cancer. 2002 Feb 12;86(4):506-11.

PMID:
11870528
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.

Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.

Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.

PMID:
22999369
[PubMed - indexed for MEDLINE]
19.

Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice.

Zhang M, Li SY, Rosenthal IM, Almeida DV, Ahmad Z, Converse PJ, Peloquin CA, Nuermberger EL, Grosset JH.

Am J Respir Crit Care Med. 2011 May 1;183(9):1254-61. doi: 10.1164/rccm.201012-1949OC. Epub 2011 Feb 17.

PMID:
21330452
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.

Everitt S, Hicks RJ, Ball D, Kron T, Schneider-Kolsky M, Walter T, Binns D, Mac Manus M.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1098-104. doi: 10.1016/j.ijrobp.2008.12.039. Epub 2009 Apr 20.

PMID:
19386444
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk